Comparison of three arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet aggregation.
Weiss
D J
DJ
Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, 1971 Commonwealth Ave, St Paul, MN 55108, USA. weiss005@umn.edu
Evanson
O A
OA
D000818:Animals; D001120:Arginine / Q000737:chemistry; D001224:Aspartic Acid / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D005998:Glycine / Q000737:chemistry; D006736:Horses; D010455:Peptides / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D001224:Aspartic Acid; D001120:Arginine; C024891:arginine aspartate; D005998:Glycine